Pharmacological challenge strategies: implications for neurochemical mechanisms in affective disorders and treatment approaches
Risch, S.C.; Kalin, N.H.; Murphy, D.L.
Journal of Clinical Psychopharmacology 1(4): 238-243
1981
ISSN/ISBN: 0271-0749 PMID: 6117587 Document Number: 174261
Document emailed within 1 workday
Related Documents
Schuman, S.H.; Kurtzman, S.B.; Fisher, J.V.; Groh, M.J.; Poston, J.H. 1978: Three approaches to the recognition of affective disorders in family practice: clinical, pharmacological, and self-rating scales Journal of Family Practice 7(4): 705-711Dilsaver, S.C. 1988: Pharmacological perturbation of cholinergic systems: applications to the study of pathophysiological mechanisms in affective disorders Hillside Journal of Clinical Psychiatry 10(1): 38-54
Naletov, S.V.; Beletskiĭ, E.A. 1998: The neurochemical mechanisms and pharmacological routes to eliminate vomiting in seasickness Voenno-Meditsinskii Zhurnal 319(9): 74-76
Pitchot, W.; Ansseau, M. 2007: Affective disorders: a pharmacological approach Revue Medicale de Liege 62(Special Issue): 21-24
Berna, C.; Desmeules, J. 2009: Cognitive and affective modulation of pain perception: mechanisms of certain clinical approaches revealed by neurosciences Revue Medicale Suisse 5(208): 1352-1355
Kharkevich, D.A.; Churiukanov, V.V. 1998: The descending cortical control of nociceptive signals: the neurochemical mechanisms and pharmacological control Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 11: 10-16
Christodorescu, D.; Zelingher, R.; Tăutu, C. 1970: A case of Klinefelter's syndrome with affective disorders and the medicolegal implications Neurologia Psihiatria Neurochirurgia 15(1): 73-76
Garganeeva, N.P.; Kartashova, I.G.; Semke, V.I. 2009: Peptic ulcer in patients with neurotic and affective disorders: comorbidity, clinicoendoscopic and psychopathological features, approaches to therapy Terapevticheskii Arkhiv 81(11): 44-48
Sulser, F. 1987: Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders Journal of Clinical Psychiatry 48 Suppl: 12-18
Vanoni, C.; Holsboer-Trachsler, E. 1997: Diagnosis and treatment of affective disorders Therapeutische Umschau. Revue Therapeutique 54(7): 386-389
Jones, G.L.; Estrada, S.D. 1972: Lithium in treatment and prevention of affective disorders Journal of the Medical Society of New Jersey 69(9): 737-739
Holmes, R.P. 1998: Pharmacological approaches in the treatment of primary hyperoxaluria Journal of Nephrology 11(Suppl): 32-35
Borison, R.L.; Ang, L.; Chang, S.; Dysken, M.; Comaty, J.E.; Davis, J.M. 1982: New pharmacological approaches in the treatment of Tourette syndrome Advances in Neurology 35: 377-382
Gindikin, V.I. 1997: The clinical picture and treatment of somatogenic affective disorders Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 97(11): 47-51
Movahed, M.R. 2013: The optimal treatment of STEMI: new pharmacological and device approaches Panminerva Medica 55(4): 339-343
Moore, G.J.; Galloway, M.P. 2002: Magnetic resonance spectroscopy: neurochemistry and treatment effects in affective disorders Psychopharmacology Bulletin 36(2): 5-23
Richards, R.J.; Thakur, V.; Reisin, E. 1996: Obesity-related hypertension: its physiological basis and pharmacological approaches to its treatment Journal of Human Hypertension 10(Suppl 3): S59-S64
Salvemini, D. 2010: Searching for new strategies for the pharmacological treatment of chronic pain Missouri Medicine 107(4): 262-264
Cavicchia, F.; Bravi, F. 1999: Case reports offer a challenge to treatment strategies for immediate implants International Journal of Periodontics and Restorative Dentistry 19(1): 66-81
Poisson, M.; Huguet, F.; Savattier, A.; Bakri-Logeais, F.; Narcisse, G. 1984: A new type of anticonvulsant, stiripentol. Pharmacological profile and neurochemical study Arzneimittel-Forschung 34(2): 199-204